您的位置: 首页 > 农业专利 > 详情页

USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
专利权人:
Salix Pharmaceuticals, Inc.;The University of Chicago
发明人:
MOSS, Jonathan,JOHNSON, Lorin K.
申请号:
EP20150851308
公开号:
EP3206491(A4)
申请日:
2015.10.16
申请国别(地区):
欧洲专利局
年份:
2018
代理人:
摘要:
Presented herein are methods for preventing or treating tumor growth, tumor metastasis and/or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充